Skip to main content
. 2020 Oct 7;11:73–103. doi: 10.2147/LCTT.S258444

Table 5.

Management of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Induced Acneiform Rash (Reactive Treatment)77

Grade Treatment of Rash TKI Treatment
1 Topical anti-inflammatory antibiotics 1% Clindamycin BID. Topical steroids like 2.5% hydrocortisone is considered, especially if the rash is itchy. Continue treatment at the current dose and monitor for bacterial super-infection or worsening of the rash.
2 Oral anti-inflammatory antibiotics like Minocycline 100 mg daily or Doxycycline 100 mg BID with topical steroid cream (hydrocortisone 2.5%, desonide, alclometasone 0.05% to the face and neck or fluocinonide 0.05% cream to chest and back) Continue treatment at the current dose and monitor for bacterial super-infection or worsening of the rash.
≥3 Dermatology referral.
Oral prednisone (0.5 mg/kg/day X 5 days) in addition to oral anti-inflammatory antibiotics like minocycline 100 mg daily or doxycycline 100 mg BID with topical steroid cream.
Low dose isotretinoin (20 to 30 mg/day) is also considered.
Interrupt the treatment.
Restart the TKI at a reduced dose once the rash is ≤ 2.
Discontinue the TKI, if the rash does not improve.

Abbreviation: TKI, tyrosine kinase inhibitors.